Duke University is a private research university in Durham, North Carolina. Founded by Methodists and Quakers in the present-day town of Trinity in 1838, the school moved to Durham in 1892.

During the past decade, Duke University conducted 503 clinical trials. In the 10-year time frame, 503 clinical trials started and 218 clinical trials were completed, i.e. on average, 43.3% percent of trials that started reached the finish line to date. In the past 5 years, 248 clinical trials started and 128 clinical trials were completed. i.e. 51.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Duke University" #1 sponsor was "Duke University" with 177 trials, followed by "NICHD Neonatal Research Network" with 37 trials sponsored, "Gilead Sciences" with 11 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 10 trials sponsored and "University of North Carolina, Chapel Hill" with 10 trials sponsored. Other sponsors include 562 different institutions and companies that sponsored additional 357 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke University" #1 collaborator was "Duke University" with 73 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 58 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 50 trials as a collaborator, "National Center for Research Resources (NCRR)" with 23 trials as a collaborator and "University of Pittsburgh" with 22 trials as a collaborator. Other collaborators include 1040 different institutions and companies that were collaborators in the rest 479 trials.

According to Clinical.Site data, the most researched conditions in "Duke University" are "Infant, Newborn" (25 trials), "Infant, Small for Gestational Age" (20 trials), "Infant, Premature" (18 trials), "Infant, Low Birth Weight" (15 trials) and "Breast Cancer" (14 trials). Many other conditions were trialed in "Duke University" in a lesser frequency.

Most popular intervention types in "Duke University" are "Drug" (326 trials), "Other" (127 trials), "Device" (125 trials), "Behavioral" (98 trials) and "Biological" (72 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (88 trials), "Pembrolizumab" (9 trials), "Nivolumab" (7 trials), "Gemcitabine" (5 trials) and "Observational" (5 trials). Other intervention names were less common.

The vast majority of trials in "Duke University" are 730 trials for "All" genders, 65 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are 254 active trials in "Duke University". 5 are not yet recruiting, 153 are recruiting, 77 are Active, not recruiting, and 19 are Enrolling by invitation. In total, there were 449 completed trials in Duke University, 7 suspended trials, and 76 terminated clinical trials to date.

Out of the total trials that were conducted in Duke University, 81 "Phase 1" clinical trials were conducted, 187 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 39 trials, and there were also 236 trials that are defined as “Not Applicable".

Duke University has several departments that took part in Clinical trials: "Duke Human Vaccine Institute - Duke Vaccine and Trials Unit" - 24 trials, "Duke University School of Nursing" - 9 trials, "Duke University Dept. of Psychiatry" - 6 trials, "Duke University Medical Center Movement Disorders Center" - 6 trials, "Duke Translational Medicine Institute - Clinical Vaccine Unit" - 6 trials, "Duke University Medical Center - Cancer Prevention, Detection and Control" - 5 trials, "Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery" - 4 trials, "Duke University Hospital Investigational Drug Services (IDS) Pharmacy" - 4 trials, "Duke University Medical Center: Division of Rheumatology and Immunology" - 3 trials, "Duke University Medical Center Genetics Dept-Site Number:840037" - 3 trials, "Duke Primary Care Research Consortium" - 2 trials, "Duke Neurology Research" - 2 trials, "Duke ALS Clinic / DUSOM Dept of Neurology / DUHS" - 2 trials, "Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program" - 2 trials, "Duke University Heart Failure Research" - 2 trials, "Duke University Medical Center, Department of Medicine - Oncology" - 2 trials, "Duke Health Behavior Neuroscience Research Lab" - 2 trials, "Duke Department of Pediatrics" - 2 trials, "Duke Department of Population Health Sciences" - 2 trials, "Duke University Dept. of Community and Family Medicine" - 2 trials, "Duke University Medical Center, Department of Anesthesiology" - 2 trials